Member Info for Scinv_temp

Https://www.linkedin.com/posts/scancell-limited_clinicaldata-cancervaccine-melanoma-activity-7312755814400708609-TCeH?utm_source=share

It is a poster even ffs. Poster session in particular. Because there are so many sections with posters (SC is section 51 iirc) they have set times for groups of sections that someone needs to be there so that people with posters don't spend all days start to finish standing by a poster and missing the rest of the conference.

Are you effing kidding me? Ffs have you all gone brain dead by reading/listening too much to what LD had to say?

Of course it's a poster, the aacr website says so and the linked in scancell posted 30min ago also says so.

@Chester there is definitely new data that they could present. But one has to be an absolute lemming to think they will do that based on what is written in the rns/abstract/linked in

Like I said, if they do it is going to signal a new era in how they communicate. But I don't expect much more than some minor update on t cell activation and correlation to efficacy, as everything they published on this suggests they do.

🤣🤣🤣🤣

* the latter is especially true for the "breakout" section.

There is new data you spoon, unless the company stopped recruiting and treating/scanning already recruited. And by the way AACR only accepts unpublished data or published with additional details (which often are minor) for the posters. So there is no "new to AACR" concept.

🤣🤣🤣

They talked about up to date data before (also at aacr and at asco) and it was the same old. So no obligation from the RNS wording.

However, if they left it vague and they actually update with new data that would be a step positive change. Doubt it.

You on the other hand are the same brain dead specimen of a human as always😂😂😂😂

Ps It's a poster you spoon🤣🤣🤣

There are 1000 posters at AACR. Almost anyone can submit anything... almost.

They gave them the actual stage last year and the company used it to give them the middle finger. So a just a poster now with the rest of the pleb, instead of poster + presentation.

😂😂😂😂😂😂😂

Only junk food for you then 😂

*18 months actually as the part of the ASCO poster that she presented is showing results from Sept 2023. To be clear, it's fine to do that in a patient conference until a more conclusive update is available, but to celebrate it in the context of an investor point of view is purely delusional 😂

It's funny how many people here are quick to point out that they have been invested here for many years. Not as an act of humility, to point out that things can go wrong. But as an act of pure delusion, that being swamped here for years is something they should be proud of. 😂

Why would anyone want to to pour cold water over a food that is already 16 months old? It was only to point out that it was deep frozen and microwaved :)

🤣🤣🤣

I guess this is part 3 of the same garbage, and, voila, it's blue! Keep it up 🤣

The sp will only go north if you make 3 parts of the same largely irrelevant post. So stop slacking.

There is not going to be any trial until the latter part of H2 2026 ffs. The earliest they would actually start working the details is end of this year, at the earliest.

By then, Trump will have changed opinion about 294 times. Not timely to discuss this.

By the way, that IT idiot who thought Google could make him understand drug development, pmj-whatever, has everything catalogued. Seek him out, but he may have been working with RM directly after some point.